Far-UVC is an emerging type of germicidal ultraviolet light. It can inactivate a wide range of pathogens with minimal effects on human tissues because it is strongly absorbed by proteins in the outer layer of human skin and eyes. It offers immense promise for continuous disinfection in occupied spaces and improved air cleaning over current alternatives.
Our Blueprint for Far-UVC documents the most up-to-date understanding of the far-UVC field and provides detailed recommendations to advance the technology from the lab to widespread deployment. We spent two years interviewing experts across photobiology, atmospheric chemistry, indoor air quality, engineering, epidemiology, and other disciplines to arrive at these recommendations.
The Airborne Infection Resilience (AIR) Program is an ambitious, coordinated five-year effort to implement those recommendations and accelerate the widespread adoption of far-UVC.